Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Orna Therapeutics
Entity

Orna Therapeutics

Tracked across 1 events · 8 articles · First seen Feb 09, 2026 · Last active Feb 09, 2026

Sentiment
90
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 90
Business
Eli Lilly Acquires Orna Therapeutics
Orna Therapeutics is being acquired by Eli Lilly and Company for up to $2.4 billion, recognizing the potential of its circular RNA technology and lead program ORN-252. This acquisition provides Orna Therapeutics with significant resources and an industry leader's backing to further develop and commercialize its innovative therapies for autoimmune diseases.
Feb 09, 2026 · 8 articles
Relationships (2)
Goodwin Procter legal counsel ↔ Orna Therapeutics Goodwin Procter is legal counsel for Orna Therapeutics in the acquisition.
Lazard financial advisor ↔ Orna Therapeutics Lazard is financial advisor for Orna Therapeutics in the acquisition.
NEWSDESK
Track Orna Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.